VANCOUVER, BRITISH COLUMBIA – February 21, 2023) – AVRICORE HEALTH INC. (TSXV: AVCR) (the “Company” or “AVCR”) has been honoured by being named as one of the 2023 Venture 50, the TSX Venture Exchange’s list of top performing companies. “To make the Venture 50 feels great and the whole team
VANCOUVER, BRITISH COLUMBIA – February 01, 2023) – AVRICORE HEALTH INC. (TSXV: AVCR) (the “Company” or “AVCR”) is entering the second year of a multi-year growth plan to bring HealthTab, its turnkey solution for point of care testing and data management, to more pharmacies across Canada and the world. As
AVRICORE HEALTH REPORTS THIRD -QUARTER 2022 RESULTS VANCOUVER, BRITISH COLUMBIA – November 29, 2022) – AVRICORE HEALTH INC. (TSXV: AVCR) (the “Company” or “AVCR”) today released its Q3 results which demonstrate significant revenue growth, indicating it can scale sustainably and deliver on its long-term objectives. The Company’s objective to create
VANCOUVER, BRITISH COLUMBIA – October 21, 2022 – AVRICORE HEALTH INC. (TSXV: AVCR) (the “Company” or “AVCR”) is excited to present at the Emerging Growth Conference on October 26th. This live, interactive online event will give existing shareholders and the investment community the opportunity to interact with the Company’s CEO, Hector Bremner
VANCOUVER, BRITISH COLUMBIA – October 11, 2022) – AVRICORE HEALTH INC. (TSXV: AVCR) (the “Company” or “AVCR”) is pleased to provide this corporate update on the Company’s execution expanding its powerful chronic-disease screening and reporting platform, HealthTab. On August 8th, the Company announced a new Master Service Agreement and Statement
VANCOUVER, BRITISH COLUMBIA – September 20, 2022 – AVRICORE HEALTH INC. (TSXV: AVCR) (the “Company” or “AVCR”) is excited to offer a live discussion on the Company’s current activities and forward outlook as it executes a significant national scale-up of its pharmacy-based point-of-care platform, HealthTab™. “We’re currently deploying a significant expansion of HealthTab
VANCOUVER, BRITISH COLUMBIA – September 19, 2022 – AVRICORE HEALTH INC. (TSXV: AVCR) (the “Company” or “AVCR”) was honoured to join the Globe and Mail’s recent Health Care Innovation event, featuring leaders from various corners of the sector, including Company CEO, Hector Bremner. “With about 40% of patients in Canada
VANCOUVER, BRITISH COLUMBIA – Aug 29, 2022) – AVRICORE HEALTH INC. (TSXV: AVCR) (the “Company” or “AVCR”) is pleased to provide this corporate update on the Company’s Q2 results. “We have now begun a new era for Healthtab™ and the Company as we expand Shoppers Drug Mart significantly over the
VANCOUVER, BRITISH COLUMBIA – August 10, 2022 – AVRICORE HEALTH INC. (TSXV: AVCR) (the “Company” or “AVCR”) is pleased to announce that the Company’s board of directors has approved the granting of stock options (the “Options”) exercisable for a total of 2,725,000 common shares to its directors, officers, and consultants
VANCOUVER, BRITISH COLUMBIA – Aug 8, 2022 – AVRICORE HEALTH INC. (TSXV: AVCR) (the “Company” or “AVCR”) is pleased to announce that the Company is significantly expanding the number of Shoppers Drug Mart pharmacies offering its HealthTab point-of-care testing platform under a renewed Master Service Agreement (MSA) to up to
